Targeted Medical Pharma, Inc.
TRGM
$0.00
$0.000.00%
12/31/2015 | 09/30/2015 | ||||
---|---|---|---|---|---|
Revenue | -17.51% | 16.40% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -17.51% | 16.40% | |||
Cost of Revenue | 3.10% | -6.97% | |||
Gross Profit | -27.15% | 31.87% | |||
SG&A Expenses | 5.69% | -8.06% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 4.83% | -7.83% | |||
Operating Income | -2,058.82% | 95.43% | |||
Income Before Tax | -154.37% | 56.47% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -154.37% | 56.47% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -144.53% | 56.47% | |||
EBIT | -2,058.82% | 95.43% | |||
EBITDA | -997.99% | 111.12% | |||
EPS Basic | -141.38% | 57.28% | |||
Normalized Basic EPS | -137.04% | 57.28% | |||
EPS Diluted | -141.38% | 57.28% | |||
Normalized Diluted EPS | -137.04% | 57.28% | |||
Average Basic Shares Outstanding | 0.85% | 1.89% | |||
Average Diluted Shares Outstanding | 0.85% | 1.89% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |